{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:46:07Z","timestamp":1789497967050,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.metabol.2021.154800","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T11:05:39Z","timestamp":1622027139000},"page":"154800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Downregulation of NK cell activities in Apolipoprotein C-III-induced hyperlipidemia resulting from lipid-induced metabolic reprogramming and crosstalk with lipid-laden dendritic cells"],"prefix":"10.1016","volume":"120","author":[{"given":"Xiangyu","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengbing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2021.154800_bb0005","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2174\/0929867324666170609081612","article-title":"APOC-III antisense oligonucleotides: a new option for the treatment of hypertriglyceridemia","volume":"25","author":"Schmitz","year":"2018","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.metabol.2021.154800_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11883-019-0791-9","article-title":"Emerging evidence that ApoC-III inhibitors provide novel options to reduce the residual CVD","volume":"21","author":"Taskinen","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.metabol.2021.154800_bb0015","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.tips.2015.07.001","article-title":"Apolipoprotein C-III: from pathophysiology to pharmacology","volume":"36","author":"Norata","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.metabol.2021.154800_bb0020","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/ATVBAHA.110.220723","article-title":"Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia","volume":"31","author":"Caron","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2021.154800_bb0025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0016-5085(03)00896-5","article-title":"Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression","volume":"125","author":"Claudel","year":"2003","journal-title":"Gastroenterology."},{"key":"10.1016\/j.metabol.2021.154800_bb0030","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/sj.ijo.0801440","article-title":"Treatment of hypertriglyceridemia by two diets rich either in unsaturated fatty acids or in carbohydrates: effects on lipoprotein subclasses, lipolytic enzymes, lipid transfer proteins, insulin and leptin","volume":"24","author":"Pieke","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2021.154800_bb0035","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2021.154800_bb0040","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia","volume":"373","author":"Gaudet","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2021.154800_bb0045","first-page":"16","article-title":"Association of multiple genetic variants with the extension and severity of coronary artery disease","volume":"110","author":"Fischer","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.metabol.2021.154800_bb0050","doi-asserted-by":"crossref","first-page":"10685","DOI":"10.1073\/pnas.1019553108","article-title":"Lowering apolipoprotein CIII delays onset of type 1 diabetes","volume":"108","author":"Holmberg","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2021.154800_bb0055","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2021.154800_bb0060","doi-asserted-by":"crossref","first-page":"14010","DOI":"10.3748\/wjg.v20.i38.14010","article-title":"Apolipoprotein C3 (\u2212455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population","volume":"20","author":"Li","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2021.154800_bb0065","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.2337\/db14-0272","article-title":"Immune cell crosstalk in obesity: a key role for costimulation?","volume":"63","author":"Seijkens","year":"2014","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154800_bb0070","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/CIRCRESAHA.114.301174","article-title":"Mechanisms that regulate macrophage burden in atherosclerosis","volume":"114","author":"Randolph","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154800_bb0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12944-016-0326-0","article-title":"APOC3 induces endothelial dysfunction through TNF-alpha and JAM-1","volume":"15","author":"Tao","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2021.154800_bb0080","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cvr\/cvv192","article-title":"Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII","volume":"107","author":"Li","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2021.154800_bb0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41590-019-0548-1","article-title":"Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation","volume":"21","author":"Zewinger","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.metabol.2021.154800_bb0090","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","article-title":"Metabolic reprogramming of natural killer cells in obesity limits antitumor responses","volume":"19","author":"Michelet","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.metabol.2021.154800_bb0095","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41419-019-1969-3","article-title":"Large triglyceride-rich lipoproteins in hypertriglyceridemia are associated with the severity of acute pancreatitis in experimental mice","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2021.154800_bb0100","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00262-018-2172-6","article-title":"Regulatory NK1.1(\u2212)CD4(+)NKG2D(+) subset induced by NKG2DL(+) cells promotes tumor evasion in mice","volume":"67","author":"Lin","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.metabol.2021.154800_bb0105","first-page":"595","article-title":"Angiopoietin-like 4 deficiency upregulates macrophage function through the dysregulation of cell-intrinsic fatty acid metabolism","volume":"10","author":"Ding","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.metabol.2021.154800_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cmet.2017.05.018","article-title":"IL-6\/Stat3-dependent induction of a distinct, obesity-associated NK cell subpopulation deteriorates energy and glucose homeostasis","volume":"26","author":"Theurich","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2021.154800_bb0115","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.4049\/jimmunol.1401558","article-title":"mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function","volume":"193","author":"Donnelly","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2021.154800_bb0120","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ni.2936","article-title":"The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells","volume":"15","author":"Marcais","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.metabol.2021.154800_bb0125","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/s41467-018-04719-2","article-title":"Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice","volume":"9","author":"Loftus","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2021.154800_bb0130","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI88894","article-title":"Distinct but complementary contributions of PPAR isotypes to energy homeostasis","volume":"127","author":"Dubois","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154800_bb0135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00005-008-0037-y","article-title":"Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma","volume":"56","author":"Zieleniak","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.metabol.2021.154800_bb0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/tri.13536","article-title":"Everolimus enhances TRAIL-mediated anti-tumor activity of liver resident natural killer cells in mice","volume":"33","author":"Saparbay","year":"2020","journal-title":"Transpl Int"},{"key":"10.1016\/j.metabol.2021.154800_bb0145","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3389\/fimmu.2019.01016","article-title":"Hematopoietic-specific deletion of foxo1 promotes NK cell specification and proliferation","volume":"10","author":"Huang","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2021.154800_bb0150","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1111\/jcmm.15478","article-title":"Thermosensitive heparin-poloxamer hydrogel encapsulated bFGF and NGF to treat spinal cord injury","volume":"24","author":"Hu","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2021.154800_bb0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/FJC.0000000000000522","article-title":"P-407-induced mouse model of dose-controlled hyperlipidemia and atherosclerosis: 25 years later","volume":"70","author":"Johnston","year":"2017","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.metabol.2021.154800_bb0160","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1139\/Y08-070","article-title":"Circulating free fatty acids are increased independently of PPARgamma activity after administration of poloxamer 407 to mice","volume":"86","author":"Johnston","year":"2008","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.metabol.2021.154800_bb0165","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1194\/jlr.M005561","article-title":"VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids","volume":"51","author":"Ruby","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2021.154800_bb0170","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","article-title":"SREBP transcription factors: master regulators of lipid homeostasis","volume":"86","author":"Eberle","year":"2004","journal-title":"Biochimie."},{"key":"10.1016\/j.metabol.2021.154800_bb0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2015.11.004","article-title":"Fatty acids, eicosanoids and PPAR gamma","volume":"785","author":"Marion-Letellier","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2021.154800_bb0180","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/eji.201344272","article-title":"Effect of tumor cells and tumor microenvironment on NK-cell function","volume":"44","author":"Vitale","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.metabol.2021.154800_bb0185","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1053\/j.gastro.2012.06.003","article-title":"Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver","volume":"143","author":"Ibrahim","year":"2012","journal-title":"Gastroenterology."},{"key":"10.1016\/j.metabol.2021.154800_bb0190","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2018.00476","article-title":"NKG2D and its ligands: \u201cone for all, all for one\u201d","volume":"9","author":"Zingoni","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2021.154800_bb0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4049\/immunohorizons.1700004","article-title":"Chronic in vivo interaction of dendritic cells expressing the ligand rae-1epsilon with NK cells impacts NKG2D expression and function","volume":"1","author":"Morvan","year":"2017","journal-title":"ImmunoHorizons."},{"key":"10.1016\/j.metabol.2021.154800_bb0200","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2005.05.026","article-title":"Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas","volume":"43","author":"Jinushi","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2021.154800_bb0205","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3389\/fimmu.2018.01324","article-title":"New insights into the regulation of natural-killer group 2 member D (NKG2D) and NKG2D-ligands: endoplasmic reticulum stress and CEA-related cell adhesion molecule 1","volume":"9","author":"Hosomi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2021.154800_bb0210","doi-asserted-by":"crossref","first-page":"L222","DOI":"10.1152\/ajplung.00327.2005","article-title":"NKG2D ligands are expressed on stressed human airway epithelial cells","volume":"291","author":"Borchers","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.metabol.2021.154800_bb0215","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00011-019-01273-5","article-title":"The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms","volume":"68","author":"Korbecki","year":"2019","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.metabol.2021.154800_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051529","article-title":"The CD36-PPARgamma pathway in metabolic disorders","volume":"19","author":"Marechal","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154800_bb0225","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(00)81574-3","article-title":"Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma","volume":"93","author":"Nagy","year":"1998","journal-title":"Cell."},{"key":"10.1016\/j.metabol.2021.154800_bb0230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12933-016-0361-1","article-title":"Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy","volume":"15","author":"Kandula","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2021.154800_bb0235","doi-asserted-by":"crossref","first-page":"3494289","DOI":"10.1155\/2017\/3494289","article-title":"FOXO transcriptional factors and long-term living","volume":"2017","author":"Murtaza","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.metabol.2021.154800_bb0240","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1038\/ncomms11023","article-title":"FoxO1-mediated autophagy is required for NK cell development and innate immunity","volume":"7","author":"Wang","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2021.154800_bb0245","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.lfs.2017.11.030","article-title":"The regulation of FOXO1 and its role in disease progression","volume":"193","author":"Xing","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.metabol.2021.154800_bb0250","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10875-009-9283-y","article-title":"Dendritic cell interactions with NK cells from different tissues","volume":"29","author":"Ferlazzo","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.metabol.2021.154800_bb0255","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2021.154800_bb0260","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.freeradbiomed.2008.04.029","article-title":"Fatty acids as modulators of the cellular production of reactive oxygen species","volume":"45","author":"Schonfeld","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.metabol.2021.154800_bb0265","first-page":"1032","article-title":"Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport","volume":"2007","author":"Schonfeld","year":"1767","journal-title":"Biochim Biophys Acta"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:28:00Z","timestamp":1758428880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049521001001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":53,"alternative-id":["S0026049521001001"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154800","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulation of NK cell activities in Apolipoprotein C-III-induced hyperlipidemia resulting from lipid-induced metabolic reprogramming and crosstalk with lipid-laden dendritic cells","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154800"}}